EarlySense, the global leader in contact-free, continuous monitoring solutions for the healthcare continuum, today announced that its patient monitoring system has received the Dutch¬†2019 Prix Galien MedTech Innovation Award. The award, which recognizes outstanding biomedical and medical technology product achievement that improve the human condition, was presented to EarlySense’s¬†Netherlands¬†distributor¬†Devices4Care.
According to the Prix Galien Jury, EarlySense’s patient monitoring device was selected for its innovative technology, usability and highly accurate results. Additionally, it was noted that EarlySense’s proven clinical impact and efficient financial models, which allow for quick upscaling, gave the device an edge over the other competing MedTech finalists. The EarlySense system has repeatedly shown to significantly reduce code blue events, bed-related falls, and pressure ulcers.
“We have been working diligently over the past several years to communicate and demonstrate the importance of contact-free, continuous monitoring in¬†the Netherlands, and are proud to receive this award which demonstrates the value EarlySense brings to healthcare professionals and patients,” said¬†Pieter Van Roon, Director of Devices4Care. “We will continue working towards our goal of supporting and improving patient safety across additional hospitals and healthcare facilities throughout the country.”
Without ever touching the patient, the EarlySense system provides continuous monitoring by using a sensor that is placed underneath a bed mattress. EarlySense’s contact-free sensor is installed in hundreds of hospitals and post-acute care facilities around the world to assist providers in early detection and prevention of potential adverse events, such as code blue events or patient falls. It assists clinicians in identifying patient deterioration before an event occurs by providing heart and respiratory rate monitoring, motion rates and bed exit alarms, to help reduce falls and pressure ulcers.
“EarlySense, together with our valued partner Devices4Care, is honored to receive the prestigious Prix Galien MedTech Innovation Award, highlighting the crucial role our technology plays in elevating patient care, and enhancing patient safety,” said¬†Tim O’Malley, President and Chief Growth Officer at EarlySense. “As we continue our global growth initiatives, we are excited to forge additional strategic partnerships with likeminded organizations and distributors who value patient safety and quality healthcare.”
